Thursday, July 9, 2026

pharma · XRTX

XORTX Therapeutics

XORTX Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

VANCOUVER, A1, USA HQ
Public company Type
XRTX · NYSE Ticker
Company details
Status
Public
HQ
VANCOUVER, A1, USA
Programs
0
Drugs
0
Patents
1
Intelligence · Clinical Programs

XORTX Therapeutics projects

0 ClinicalTrials.gov programs sponsored by XORTX Therapeutics.

XORTX Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does XORTX Therapeutics have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.